Drug Type Small molecule drug |
Synonyms AP-1, AP 1001, AP1001 |
Target |
Action agonists |
Mechanism SSTR4 agonists(Somatostatin receptor 4 agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Trigeminal Neuralgia | Preclinical | Denmark | 01 Apr 2026 | |
| Diabetic peripheral neuropathy | Preclinical | Denmark | 01 Apr 2025 | |
| Idiopathic Pulmonary Fibrosis | Discovery | Denmark | 01 Apr 2026 |





